Cin­Rx touts pos­i­tive ear­ly-stage da­ta from two obe­si­ty can­di­dates

Cin­Fi­na Phar­ma, a sub­sidiary of the hub-and-spoke biotech Cin­Rx, shared ear­ly-stage da­ta for two of its Janssen-li­censed obe­si­ty can­di­dates at this year’s Obe­si­ty­Week.

CIN-110, a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER